Background: The usefulness of tumor markers in NSCLC is not well defined. High levels of CEA are considered a negative prognostic factor in early-stages NSCLC but its role in advanced disease is yet ...
We used electronic health record data from an integrated health system on a cohort of patients diagnosed with American Joint Committee on Cancer stage I-III CRC between 2008 and 2013 (N = 3,970) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback